Datar Cancer Genetics partners with Kokilaben Dhirubhai Ambani Hospital for cancer detection

The cancer screening tests include EasyCheck360 and EasyCheck Femmesafe

Datar Cancer Genetics has announced an association with Kokilaben Dhirubhai Ambani Hospital, Mumbai, to bring their series of unique revolutionary blood tests for early and easy detection of cancer. The cancer screening tests include EasyCheck360 and EasyCheck Femmesafe. The EasyCheck cancer tests will help in early detection of cancer that is critical for successful treatment and cure. These easy blood tests overcome the challenges of conventional cancer screening procedures that are invasive and resource intensive.

The EasyCheck360, EasyCheck Femmesafe and EasyCheck Prostrate are early cancer screening tests that detect the existence of cancer. The EasyCheck360 is not a genetic predisposition test and is a real time test. The test also indicates the location for the select types of cancers with high accuracy, and in others the tissue of origin can be identified. A ‘positive’ result is interpreted by the oncologist for further course of action.

The tests analyse CTC in the peripheral blood of an individual, are intended to detect the presence of malignant cells.

There are 2 tests that are currently available at Kokilaben Dhirubhai Ambani Hospital:

EasyCheck360: This one is intended to be performed annually as a screening test on individuals aged 30 years and above without any symptoms suggestive of cancer.  It screens for about 30 types of cancer.

EasyCheck-FemmeSafe: This one is intended to be performed annually as a screening test on women aged 30 years and above  without any symptoms suggestive of cancer. It screens for 4 types of cancer.